Physician profile
Jay A Young
NPI 1396826368
$4,861.85
in general payments reported to CMS, 2019-2025
29 companies · $63.96 in 2025
The $63.96 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $335 · 2020: $3,586 · 2021: $355 · 2022: $428 · 2023: $60.67 · 2024: $32.86 · 2025: $63.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $157.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,309.72 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $262.33 | 2019-2022 | |
| Stryker Corporation | $224.00 | 2020 | |
| La Jolla Pharmaceutical Company | $91.34 | 2021-2023 | Xerava |
| Kowa Pharmaceuticals America, INC. | $91.27 | 2022 | |
| Ethicon US, LLC | $77.74 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $75.60 | 2019-2021 | |
| Axonics, INC. | $73.58 | 2020-2021 | |
| Braintree Laboratories, INC. | $70.55 | 2019-2022 | |
| Thd America, INC. | $67.74 | 2019-2023 | |
| Medtronic, INC. | $65.34 | 2024-2025 | Interstim, Maxtack |
| Sanara Medtech INC. | $61.98 | 2022-2023 | Celleraterx |
| Zyla Life Sciences, INC. | $52.71 | 2019-2020 | |
| Covidien Lp | $51.05 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.22 | 2019-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $30.72 | 2019-2020 | |
| Baxter Healthcare | $23.07 | 2021-2022 | |
| Tela Bio, INC. | $22.72 | 2019 | |
| Ambu INC. | $20.05 | 2022 | |
| Capsovision, INC. | $18.22 | 2025 | Capsocam Plus |
| Abbott Laboratories | $16.17 | 2022 | |
| Acell, INC. | $15.83 | 2020 | |
| Shire North American Group INC | $14.93 | 2019 | |
| Merck Sharp & Dohme LLC | $14.46 | 2019 | |
| Kci USA, INC. | $14.19 | 2019 | |
| Boston Scientific Corporation | $13.26 | 2025 | Axonics |
| Convatec INC. | $12.68 | 2019 | |
| Triad Life Sciences INC. | $12.65 | 2022 | |
| Coopersurgical, INC. | $11.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.